Renaissance Technologies — Unmapped CUSIP

How Renaissance Technologies's position in Bridgebio Oncology Therapeut changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 107924102 needs mapping

Quarters held

2

First reported

Q1 2026

Latest value

$446,532

Latest weight

0%

Peak weight

0%

Shares since first

-42.5%

Position Trend

Shares, value, and weight from first report to latest report.

Renaissance Technologies first reported 101,900 shares in Q1 2026 and most recently reported 58,600 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q2 2026.

Since the first report, shares are -42.5% and reported value is -51%. Latest move: TRIM